FALIPHARMA
The computed 12-month bankruptcy probability of FALIPHARMA is 0.7% (low). The company has been active since 1982 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 43 yrs |
| Board | 3 |
| Locations | 2 |
| Publications | 4 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 19-08-2025 | 2025-00385567 |
| 31-12-2023 | volledig | 21-08-2024 | 2024-00359391 |
| 31-12-2022 | volledig | 13-07-2023 | 2023-00238473 |
| 31-12-2021 | volledig | 06-07-2022 | 2022-20164684 |
| 31-12-2020 | volledig | 09-08-2021 | 2021-47500316 |
| 31-12-2019 | volledig | 14-08-2020 | 2020-41800285 |
| 31-12-2018 | volledig | 16-09-2019 | 2019-64900268 |
| 31-12-2017 | volledig | 29-08-2018 | 2018-53700500 |
| 31-12-2016 | volledig | 26-07-2017 | 2017-37900374 |
| 31-12-2015 | volledig | 02-08-2016 | 2016-39500164 |
-
Jaroline PharmaLegal entityDirector· perm. rep.: Céline RuthState Gazette act 26020820 (10-02-2026)Current01-01-2026 → present
-
Current01-01-2026 → present
-
RUTH CélineLegal entityDirector· perm. rep.: FLAMENG JonathanState Gazette act 21369678 (29-11-2021)Current01-01-2015 → present
2 events
- 29-11-2021 Mandate renewed· Director
- 01-01-2015 Appointed· Managing director
Former directors (1)
-
Former- → 29-11-2021
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 31-08-1982 |
| Status | Active |
| Postal code | 5060 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92041A0075/00Z003 | Wallonia | 638 m² | 1 · 82 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-08-2026 General meeting · Seat change · Permanent representative
- Publication: 04/08/2026 · FALIPHARMA
- Filing: 16/07/2026 · FALIPHARMA
- General meeting: 05/05/2026 · FALIPHARMA
- Seat change: to: Rue J.J. Merlot(FAL) 3A - 5060 Sambreville · FALIPHARMA
- Permanent representative · Céline RUTH
Technical details
{
"facts": [
{
"date": "2026-08-04",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 04/08/2026",
"value": "04/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-16",
"type": "filing",
"quote": "D\u00E9pos\u00E9 au Greffe du Tribunal de l\u0027entreprise de Li\u00E8ge division Namur 16 JUIL. 2026",
"value": "16/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-05-05",
"type": "general_meeting",
"quote": "Extrait du PV de I\u0027AGE du 05/05/2026",
"value": "05/05/2026",
"object": null,
"subject": "e1"
},
{
"type": "seat_change",
"quote": "Erratum: une erreur a \u00E9t\u00E9 constat\u00E9e dans la publication du 31-12-2025 concernant le transfert du si\u00E8ge social. L\u0027adresse correcte du si\u00E8ge social est la suivante: Rue J.J. Merlot(FAL) 3A - 5060 Sambreville",
"value": {
"to": "Rue J.J. Merlot(FAL) 3A - 5060 Sambreville",
"from": null,
"effective_date": null
},
"object": null,
"subject": "e1",
"_value_raw": {
"to": "Rue J.J. Merlot(FAL) 3A - 5060 Sambreville",
"note": "Erratum correcting previous publication"
}
},
{
"type": "permanent_representative",
"quote": "C\u00E9line RUTH Repr\u00E9sentant permanent de JAROLINE PHARMA SRL",
"value": null,
"object": "e3",
"subject": "e2"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1150,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0422.990.373",
"kind": "company",
"name": "FALIPHARMA",
"attrs": {
"seat": "Rue J.J. Merlot(FAL) 3A - 5060 Sambreville",
"legal_form": "SRL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "C\u00E9line RUTH",
"attrs": {
"role": "Repr\u00E9sentant permanent de JAROLINE PHARMA SRL, Administrateur"
}
},
{
"id": "e3",
"kbo": null,
"kind": "company",
"name": "JAROLINE PHARMA SRL",
"attrs": {}
}
]
}10-02-2026 2 directors appointed
- Scailquin Anne Marie, Bestuurder
- Céline Ruth, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Scailquin Anne Marie",
"address": null,
"birth_date": null
},
"effective_date": "2026-01-01",
"evidence_quote": "Nomination en qualit\u00E9 d\u0027administrateur de Mme Scailquin Anne Marie;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "C\u00E9line Ruth",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1023796101",
"name": "Jaroline Pharma SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-01-01",
"evidence_quote": "Nomination en qualit\u00E9 d\u0027administrateur de Jaroline Pharma SRL, repris \u00E0 la BCE sous le num\u00E9ro d\u0027entreprise 1023.796.101, dont le repr\u00E9sentant permanent est Mme C\u00E9line Ruth."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0422.990.373",
"name_full": "FALIPHARMA",
"legal_form": "SRL"
}
}29-11-2021 1 resigning, 1 reappointed
- Gérant actuel, Zaakvoerder
- FLAMENG Jonathan, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "FLAMENG Jonathan",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "RUTH C\u00E9line",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de sa nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e : \u2022 Madame RUTH C\u00E9line, domicili\u00E9e \u00E0 5070 Fosses-la-Ville (Vitrival), Rue Rauhisse 47"
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "G\u00E9rant actuel",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s... L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9charge compl\u00E8tement le g\u00E9rant d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"discharge_granted": true
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0422.990.373",
"name_full": "FALIPHARMA",
"legal_form": "SPRL"
}
}20-02-2015 Céline RUTH appointed as managing director
- Céline RUTH, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "C\u00E9line RUTH",
"address": null,
"birth_date": null
},
"effective_date": "2015-01-01",
"evidence_quote": "Mademoiselle C\u00E9line RUTH est nomm\u00E9e comme deuxi\u00E8me g\u00E9rante de la soci\u00E9t\u00E9 avec effet au 1er janvier 2015."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0422.990.373",
"name_full": "FALIPHARMA",
"legal_form": "SPRL"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | FALIPHARMA |